Article Type
Article
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Topical vs. IV Vancomycin for MRSA

Article PDF
021040075_3.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 21(4)
Publications
Federal Practitioner
Page Number
83
Legacy Keywords
antibiotic therapy, infectious diseases, IV, topical, vancomycin, MRSA, methicillin resistant staphylococcus aureusantibiotic therapy, infectious diseases, IV, topical, vancomycin, MRSA, methicillin resistant staphylococcus aureus
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
021040075_3.pdf
Article PDF
021040075_3.pdf

Issue
Federal Practitioner - 21(4)
Issue
Federal Practitioner - 21(4)
Page Number
83
Page Number
83
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
Topical vs. IV Vancomycin for MRSA
Display Headline
Topical vs. IV Vancomycin for MRSA
Legacy Keywords
antibiotic therapy, infectious diseases, IV, topical, vancomycin, MRSA, methicillin resistant staphylococcus aureusantibiotic therapy, infectious diseases, IV, topical, vancomycin, MRSA, methicillin resistant staphylococcus aureus
Legacy Keywords
antibiotic therapy, infectious diseases, IV, topical, vancomycin, MRSA, methicillin resistant staphylococcus aureusantibiotic therapy, infectious diseases, IV, topical, vancomycin, MRSA, methicillin resistant staphylococcus aureus
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media